The capacity of intramuscular (i.m.) inoculation of mice with homologous or heterologous host rotaviruses to induce protection from challenge was evaluated. i.m. inoculation with live, wild-type rotavirus (murine strain EDIM) induced complete protection from viral shedding after challenge for at least 6 weeks after inoculation; protection was correlated with production of virus-specific immunoglobulin A (IgA) by lamina propria (LP) lymphocytes. i.m. inoculation with inactivated EDIM, cell culture-adapted EDIM, or simian strain RRV was associated with partial protection, characterized by reduced viral shedding after challenge. Partial protection after challenge was not associated with production of virus-specific IgA by LP lymphocytes. The mechanisms by which i.m. inoculation induces virus-specific humoral immune responses in the small intestinal LP were examined.
For decades parenteral immunization has been used to stimulate protection against pathogens whose site of replication is limited to mucosal surfaces (e.g., influenza viruses and Bordetella pertussis). In addition to inducing protection from mucosal diseases, parenterally administered vaccines have also been shown to induce immune responses active at mucosal surfaces. Limited viral shedding in pharyngeal secretions and feces has been observed among inactivated poliovirus vaccine recipients following exposure to wild-type poliovirus (10) or oral polio vaccine (9) . Furthermore, parenteral inoculation has been shown to induce the production of pathogen-specific humoral (1, 3-5, 22, 31) and cellular (20) immune responses at mucosal surfaces following immunization with either experimental or licensed vaccines.
Similar to influenza virus and B. pertussis, rotavirus is a pathogen whose site of replication is limited to the mucosal surface. Prior studies have demonstrated the capacity of intramuscular (i.m.) inoculation of rotavirus to induce production of virusspecific immunoglobulin A (IgA) by small intestinal lamina propria (LP) lymphocytes (3) . However, little is known about the mechanisms by which mucosal immune responses are induced by parenteral immunization or the immunologic correlates associated with protection against challenge.
We examined the relative capacities of wild-type, cell culture-adapted, or inactivated rotaviruses to induce protection in mice after i.m. inoculation and attempted to correlate protection with virus-specific humoral immune responses in serum, intestinal contents, and intestinal and nonintestinal lymphoid tissues. Kinetic studies of virus-specific antibody responses in intestinal and nonintestinal lymphoid tissues were performed to determine possible mechanisms by which humoral immune responses are generated at mucosal surfaces after i.m. inoculation.
HEPES (Mediatech, Washington, D.C.), once in HBSS with 0.05% EDTA to free the epithelium from the basement membrane and allow intraepithelial lymphocytes to be removed, and twice in HBSS. Under a dissecting microscope at ϫ30 magnification, fat, mesentery, and connective tissue were removed from small intestinal segments. Eight LP fragments (1 by 1 mm) from small intestinal segments of each animal were removed and placed in individual wells of a 24-well plate containing 1 ml of gut-associated lymphoid tissue (GALT) medium (Kennet's HY medium [Gibco] , streptomycin [100 g/ml; JRH], 50 and 0.25 g of gentamicin and amphotericin B [Fungizone; JRH] per ml, respectively). Samples were incubated at 37°C in an atmosphere of 95% O 2 and 5% CO 2 for 5 days. Supernatant fluids were collected and subsequently tested for the presence of virus-specific and total IgM, IgA, and IgG by ELISA. Antibody quantities from LP fragments were multiplied by a factor of 340 to account for the total surface area of the small intestine.
Intestinal and nonintestinal lymphoid cultures. Lymphoid cultures of LP, mesenteric lymph nodes (MLN), Peyer's patches (PP), inguinal lymph nodes (ILN), and popliteal lymph nodes (POP) were established by using three mice per group at 4, 7, 9, 11, and 14 days after i.m. inoculation with wild-type EDIM as previously described (3). Briefly, under sterile conditions ILN, POP, MLN, and small intestines were isolated. ILN, POP, and MLN were washed twice in Iscove's modified Dulbecco's medium (Gibco) containing gentamicin (50 g/ml; JRH) and placed in individual wells of a 24-well plate (Becton Dickinson) with GALT medium (1 ml/well). Samples were incubated at 37°C in an atmosphere of 95% O 2 and 5% CO 2 for 5 days. LP lymphoid cultures were performed as described above. Supernatant fluids were collected and subsequently tested for the presence of virus-specific and total immunoglobulins by ELISA. Antibody quantities from LP fragments were calculated as described above. Antibody quantities produced by PP were multiplied by a factor of 12 to account for the average number of PP within the small intestine (29) .
Detection of virus-specific antibodies and total immunoglobulins by ELISA. Sera, intestinal contents, and supernatant fluids from intestinal and nonintestinal lymphoid cultures were tested for rotavirus-specific and total quantities of IgM, IgA, and IgG as described previously (12) .
Detection of rotavirus antigen by ELISA. Fecal suspensions (10% [wt/vol]) were tested for the presence of rotavirus antigen. Individual wells of 96-well, flat-bottomed, high-binding plates (Costar, Cambridge, Mass.) were coated with 100 l of cow antirotavirus (bovine strain WC3) hyperimmune sera diluted 1:2,000 in a solution containing 1.5 mM sodium carbonate and 3.5 mM sodium bicarbonate. Plates were covered and incubated in a humidified atmosphere at 4°C overnight. Plates were washed (in a MultiReagent Plate Washer; Dynatech, Chantilly, Va.) four times with a wash buffer solution containing 1.73 M NaCl, 0.03 M KH 2 PO 4 , 0.13 M Na 2 HPO 4 , and 0.25% Tween 20 (Sigma, St. Louis, Mo.) and two times with dH 2 O and treated at room temperature for 1 h with a solution containing 0.5% gelatin (Sigma) and 0.05% Tween 20 (200 l/well). Wells were washed four times with wash buffer and two times with dH 2 O. Undiluted, homogenized fecal samples (50 l) were added to experimental wells, and 50 l of a solution containing 0.5% gelatin and 0.05% Tween 20 was added to control wells. After incubation at room temperature for 1 h, wells were washed four times with wash buffer and two times with dH 2 O. Rabbit antirotavirus (bovine strain WC3) hyperimmune serum diluted 1:2,000 in a solution containing 0.5% gelatin and 0.05% Tween 20 was added to individual wells (100 l/well) and incubated at room temperature for 1 h. Wells were washed four times with wash buffer and two times with dH 2 O, and alkaline phosphatase-conjugated goat anti-rabbit IgG (100 l/well; Cappel, Durham, N.C.) was added. After incubation at room temperature for 1 h, plates were washed four times with wash buffer and two times with distilled water. A 1 M diethanolamine and p-nitrophenyl phosphate solution (100 l/well; Kirkegaard and Perry Laboratories, Gaithersburg, Md.) was added to each well. After incubation at room temperature for 90 min, plates were read at a wavelength of 405 nm on an ELISA plate reader (Dynatech). A sample was considered positive if the optical density (OD) in the experimental well was Ͼ0.1 OD units and 2-fold greater than the OD in the corresponding control well. For each assay, purified rotavirus was used to generate a standard curve and the quantity of viral antigen in experimental wells was calculated.
Detection of rotavirus antigen in villous epithelial cells by indirect immunofluorescence assay. At 48 h after i.m. or oral inoculation of mice with 200 l of wild-type EDIM virus, small intestines were harvested. Intestinal contents were removed by washing with phosphate-buffered saline (PBS), and tissue was mounted in Optimal Cutting Temperature compound (Tissue-Tek; Sakura Finetek, Torrance, Calif.) prior to freezing. Tissue sections 20 m in width were cut (2800 Frigocut N; Reichert-Jung, Berlin, Germany) and mounted on charged slides (Superfrost/Plus; Fisher Scientific, Pittsburgh, Pa.). After two washes in PBS, slides were incubated overnight at 4°C in a 1:100 dilution of rabbit antirotavirus hyperimmune serum in PBS. Slides were washed in PBS and incubated for 1 h at room temperature with a 1:500 dilution of fluorescein isothiocyanate (FITC)-conjugated mouse anti-rabbit immunoglobulins (Sigma) in PBS.
Statistical analysis. Differences in concentrations of antibodies were evaluated by the Mann-Whitney U test. Comparisons resulting in P values of Ͻ0.05 were considered to indicate significant differences.
RESULTS
i.m. inoculation with EDIM induces complete protection against EDIM challenge. To evaluate the capacity of homologous host rotavirus to induce protection against challenge, (Table 1) . By 16 weeks after primary inoculation, low levels of viral shedding were detected. i.m. inoculation with cell culture-adapted EDIM induced partial protection after challenge. A 10-fold reduction in total mean quantity of viral antigen shed upon challenge was observed 6 weeks after i.m. inoculation with cell culture-adapted EDIM virus compared to buffer. Complete protection against challenge after i.m. inoculation with EDIM is associated with production of virus-specific IgA by LP lymphocytes and detection of virus-specific IgA at the intestinal mucosal surface and in serum. To determine the immunologic correlates of complete protection following i.m. inoculation, LP lymphoid cultures and intestinal washes were performed 6 weeks after i.m. inoculation with wild-type EDIM. Rotavirus-specific IgA was produced by LP lymphocytes (Table 2) and detected at the intestinal mucosal surface (Table 3) and in serum (data not shown) after i.m. inoculation with live, wild-type EDIM.
Partial protection against challenge after i.m. inoculation with cell culture-adapted EDIM, inactivated EDIM, or RRV is not associated with production of virus-specific IgA in GALT. To determine the capacity of i.m. inoculation with cell cultureadapted homologous or heterologous host rotavirus or inactivated homologous host rotavirus to induce protection against challenge, mice were immunized i.m. with cell culture-adapted EDIM or RRV or inactivated EDIM and subsequently challenged with wild-type EDIM. Partial protection was observed 6 weeks after i.m. inoculation with RRV, cell culture-adapted EDIM, or inactivated EDIM (Table 1) . Partial protection was characterized by a reduced magnitude and a more rapid resolution of viral shedding (Fig. 1) . Although viral shedding was reduced 1 day after challenge, virus-specific IgA was neither produced by LP lymphocytes nor detected at the intestinal mucosal surface at the time of challenge. LP lymphocytes did not produce virus-specific IgA until 6 days after challenge in both naive and RRV-inoculated mice (Fig. 2A) . The quantity of virus-specific IgA produced by LP lymphocytes 6 days after challenge was greater in previously inoculated mice (EDIM, P Ͻ 0.05; RRV, P ϭ 0.21) compared to naive mice.
Virus-specific IgG is produced by LP lymphocytes and detected at the intestinal mucosal surface after i.m. inoculation. Six weeks after i.m. inoculation with cell culture-adapted EDIM, inactivated EDIM, or RRV, virus-specific IgG was produced by LP lymphocytes (Table 2 ) and detected in the serum (data not shown); 0.97 to 19.65% of the total IgG produced by LP lymphocytes was rotavirus specific ( Table 2) . Production of virus-specific IgG by LP lymphocytes was associated with a reduction in viral shedding after challenge (Tables 1 and 2). Virus-specific, IgA-secreting plasma cells are detected initially in PP and MLN and not in draining ILN after i.m. inoculation. To determine the source of virus-specific IgAproducing cells in the LP following i.m. inoculation with wildtype EDIM, lymphoid cultures of GALT and systemic lymphoid tissues were established 4, 7, 9, 11, and 14 days after unilateral i.m. inoculation. Production of virus-specific IgM by the draining (ipsilateral) lymph nodes occurred 4 days after inoculation and preceded production of virus-specific IgM by GALT (Table 4) . On the other hand, rotavirus-specific IgA was initially produced by lymphocytes in PP and MLN 7 days after inoculation and by LP lymphocytes 11 days after inoculation. No virus-specific IgA was produced by the draining lymph nodes or nondraining (contralateral) lymph nodes up to 14 days after i.m. inoculation.
Mice inoculated i.m. with EDIM are not inadvertently inoculated by the oral route. We evaluated the possibility of an unrecognized, coincidental oral inoculation after i.m. inoculation with live, wild-type EDIM. First, fecal pellets were collected and small intestines were harvested from mice 1 to 7 days after i.m. inoculation with 10 6 SD 50 of live, wild-type EDIM; viral antigen was not detected in any specimen (data not shown). On the other hand, oral inoculation of mice with 10 0 SD 50 of live, wild-type EDIM resulted in viral shedding detected in feces up to 7 days after inoculation (data not shown). Second, intestinal homogenates (diluted 1:10) obtained 3 days after i.m. inoculation of adult mice with live, wild-type EDIM (equivalent to 10 6 SD 50 ) did not induce diarrhea in suckling mice or induce shedding in adult mice after oral inoculation. Third, rotavirus antigen was not detected by indirect immunofluorescence in sections of small intestine obtained 48 h after i.m. inoculation with live, wild-type EDIM (data not shown).
DISCUSSION
We found that i.m. inoculation of mice with homologous host rotavirus induced production of virus-specific IgA by LP lymphocytes. Virus-specific IgA was also detected at the intestinal mucosal surface and was associated with prevention of viral shedding after challenge. While induction of antigenspecific antibodies and protection from mucosal infection after parenteral immunization have been described previously (1, 3-6, 16, 17, 25, 27) , we believe our study is the first to demonstrate that complete protection from a mucosal pathogen after immunization by a nonmucosal route is correlated with production of antigen-specific IgA by LP lymphocytes.
There are a number of mechanisms by which parenteral immunization may induce production of virus-specific IgA by GALT. First, virus may disseminate by blood to GALT and stimulate an immune response after processing by intestinal antigen-presenting cells (APCs). We found no evidence that EDIM virus either entered GALT or infected small intestinal epithelial cells. Second, virus-specific IgA-secreting plasma cells may be generated in draining lymph nodes and home to GALT. Although nonmucosal lymphocytes are capable of producing IgA (18), we found no evidence that virus-specific IgAsecreting plasma cells arose from systemic lymphoid tissue. Third, activated virus-specific B lymphocytes may be generated in draining lymph nodes, disseminate to GALT, and, in the presence of cytokines supportive of IgA production, differentiate to IgA-secreting cells. This hypothesis is supported by our observation that virus-specific IgM-secreting lymphocytes were detected in draining lymph nodes prior to detection of either virus-specific IgM-or IgA-secreting cells in GALT. Following homing to GALT, activated lymphocytes committed to production of virus-specific antibodies may undergo preferential isotype switching to IgA secretion under the influence of cytokines such as interleukin 4 (IL-4), IL-5, or IL-10 (15). Fourth, APCs capable of presenting rotavirus-specific peptides may be generated in draining lymph nodes and traffic to GALT. This finding is also consistent with our observation that virus-specific IgA is first detected in PP and MLN and only later detected in the LP. After IM inoculation, APCs may migrate from draining lymph nodes to PP, where they initiate the production of virus-specific IgA-secreting cells which subsequently traffic through the MLN and home to LP. Finally, parenterally administered live rotaviruses may undergo an abortive cycle of replication in extraintestinal tissues.
Virus-specific IgA production by LP lymphocytes was induced by i.m. inoculation with live, wild-type EDIM but not by viruses less well adapted to replication in vivo (i.e., cell cultureadapted EDIM and RRV). Although viral replication has been shown to be important in induction of virus-specific IgA responses in GALT after oral inoculation (13, 28) , i.m. inoculation of suckling mice with large quantities of inactivated RRV has been shown to induce production of virus-specific IgA by GALT (3). Taken together, these results suggest that the quantity of antigen delivered to immunologic inductive sites may influence the production of virus-specific IgA by GALT. Although differences in protective efficacy and production of virus-specific IgA by GALT after inoculation with wild-type or cell culture-adapted rotaviruses may be related to the dose of infectious virus administered, differences in host cell range of (14) . Low levels of viral shedding were detected 16 weeks after primary inoculation, suggesting that complete protection after parenteral immunization may not be long lasting. Additional experiments are needed to determine the durability of protection following i.m. immunization and the duration of virusspecific IgA and IgG production by LP lymphocytes.
Partial protection after i.m. inoculation with inactivated or cell culture-adapted rotaviruses was characterized by a reduction in the magnitude and duration of viral shedding; protection occurred in the absence of either virus-specific IgA production by LP lymphocytes or virus-specific IgA at the intestinal mucosal surface at the time of challenge. Reduced shedding was noted within 24 h of challenge, consistent with an immunologic effector function present at the intestinal mucosal surface at the time of challenge or generated within 24 h of challenge. Although virus-specific IgG was produced by GALT at the time of challenge, its importance in protection against shedding after i.m. inoculation remains unclear. Prior work has demonstrated that antigen-specific IgG can protect against mucosal challenge (15) and decrease mucosal viral shedding (2, 16, 23) . Conner and coworkers found that i.m. inoculation of rabbits with two doses of heterologous host rotavirus and Freund's adjuvant induced protection from homologous host rotavirus challenge and correlated with the presence of fecal virus-specific IgG (4). In our study, levels of viral shedding after inoculation of mice with inactivated, wild-type EDIM or RRV were almost identical even though virus-specific IgG production represented about 1 and 20%, respectively, of total IgG produced by the LP. In addition, mice were partially protected from challenge in the absence of detectable rotavirus-specific IgG at the intestinal surface. Alternatively, virusspecific CD4 ϩ memory cells may reside within the intestinal mucosa and be stimulated to elaborate cytokines with direct antiviral activity, such as alpha interferon, upon rotavirus challenge.
Production of virus-specific IgA by LP lymphocytes was first detected 6 days after EDIM challenge in both RRV-inoculated and naive mice. However, greater quantities of rotavirus-specific IgA were elaborated by the LP lymphocytes of previously immunized mice. This observation suggests that i.m. inoculation may prime for an anamnestic response in GALT characterized by greater quantities, but not an earlier appearance, of virus-specific IgA in the LP. The time required for activation, differentiation, and possibly trafficking and homing of memory B cells to the LP may be the same as that required for induction of naive B cells in PP to virus-specific, IgA-secreting plasma cells in the LP.
Virus-specific cytotoxic T lymphocytes (CTLs) may be important in reduction of viral shedding after i.m. inoculation with inactivated or cell culture-adapted EDIM or RRV. However, there are several reasons why this possibility is unlikely. First, it is unlikely that CTL precursors in GALT would be activated and differentiate to effector cells within 24 h of challenge. Second, virus-specific CTL effectors were not detected at the intestinal mucosal surface (i.e., among villous epithelial lymphocytes) after subcutaneous inoculation of C57BL/6 mice with RRV (21) . Third, studies of J H D and ␤ 2 -microglobulin knockout mice found that protection against viral shedding associated with reinfection was dependent upon virus-specific humoral but not virus-specific CTL responses (7) . To exclude the possibility that virus-specific CTLs are associated with reduced shedding, we will examine the kinetics of induction of CTL precursors and CTL effector cells after i.m. inoculation of BALB/c mice with inactivated EDIM as well as cell cultureadapted EDIM or RRV.
We found that virus-specific IgG was produced by LP lymphocytes and detected at the intestinal mucosal surface after i.m. inoculation. IgG has been shown to migrate across epithelial cells when it is cross-linked through multivalent antigen to polymeric IgA (11) , suggesting that IgG may contribute to mucosal protection through intracellular association with antigen and subsequent activation of complement. Antigen-specific IgG may also protect mucosal surfaces through direct neutralization of viral infectivity (24) . However, the mechanism by which virus-specific IgG may be detected at the intestinal surface in the absence of antigen is unknown.
